⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

March 3, 2026Open Access

HPF: A Holistic Framework for Decision-Readiness in Pharmaceutical Portfolio Management

View Full Paper

Ask AI

Bookmark

Share

Key Points

To develop a holistic framework that enhances decision-readiness in managing pharmaceutical portfolios.
Framework development based on existing portfolio management strategies.
Analysis of decision-making processes in pharmaceutical contexts.
Evaluation of the framework’s effectiveness in real-world applications.
The framework improves clarity in decision-making procedures.
Strategic alignment is enhanced across product portfolios.
Stakeholder engagement in decision processes is significantly increased.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Research demonstrates a holistic framework for decision-readiness in pharmaceutical portfolio management, suggesting improved strategic planning.

Abstract

Research article: HPF: A Holistic Framework for Decision-Readiness in Pharmaceutical Portfolio Management

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Oleh Ivchenko (2026) studied this question.

synapsesocial.com/papers/69a91e4cd6127c7a504c2161 https://doi.org/10.5281/zenodo.18845421

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1HPF-P Validation Studies: Empirical Benchmarking of Decision Readiness Across Pharmaceutical ContextsOriginal Research · 2026
2HPF Experimental Validation: Multi-Strategy Portfolio Optimization for Ukrainian Pharmaceutical MarketsOriginal Research · 2026
3Multi-Scenario Stress Testing for HPF-P Pharmaceutical PortfoliosOriginal Research · 2026
4Integrating DRI and DRL: A Unified Decision Readiness Assessment Protocol for HPF-POriginal Research · 2026
5Comparative Benchmarking: HPF-P vs Traditional Portfolio MethodsOriginal Research · 2026
6Strategic Product Portfolio Management in the Pharmaceutical Industry: Market Intelligence, Regulatory Insight, and Stage-Gate Decision-MakingReview · 2026
7Decision Readiness Level (DRL): Operationalizing Maturity Assessment for AI-Augmented Pharmaceutical Portfolio ManagementOriginal Research · 2026
8HPF-P in Practice: Deployment Lessons and Future DirectionsOriginal Research · 2026

More from Odessa National Polytechnic University